Sunflower Pharmaceuticals Group Co Ltd (002737) — Net Asset Quality Index
Sunflower Pharmaceuticals Group Co Ltd (002737) has a Net Asset Quality Index of 76.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.36 Billion minus total liabilities of CN¥1.25 Billion yields net assets of CN¥4.11 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 002737 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sunflower Pharmaceuticals Group Co Ltd Net Asset Quality Index Over Time (2011–2025)
This chart shows how Sunflower Pharmaceuticals Group Co Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 76.7%, representing net assets of CN¥4.11 Billion against total assets of CN¥5.36 Billion CNY. See working capital position of Sunflower Pharmaceuticals Group Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Sunflower Pharmaceuticals Group Co Ltd (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 002737 stock market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.9% | CN¥3.99 Billion | CN¥5.33 Billion | CN¥1.34 Billion | ▼ -3.9 pp |
| 2024 | 78.8% | CN¥4.59 Billion | CN¥5.83 Billion | CN¥1.24 Billion | ▲ +6.1 pp |
| 2023 | 72.7% | CN¥5.00 Billion | CN¥6.88 Billion | CN¥1.88 Billion | ▲ +9.6 pp |
| 2022 | 63.1% | CN¥4.44 Billion | CN¥7.03 Billion | CN¥2.59 Billion | ▼ -6.7 pp |
| 2021 | 69.8% | CN¥3.94 Billion | CN¥5.64 Billion | CN¥1.70 Billion | ▲ +3.5 pp |
| 2020 | 66.3% | CN¥3.39 Billion | CN¥5.11 Billion | CN¥1.72 Billion | ▲ +1.7 pp |
| 2019 | 64.6% | CN¥3.43 Billion | CN¥5.31 Billion | CN¥1.88 Billion | ▼ -3.3 pp |
| 2018 | 67.9% | CN¥3.44 Billion | CN¥5.06 Billion | CN¥1.62 Billion | ▼ -2.8 pp |
| 2017 | 70.7% | CN¥3.16 Billion | CN¥4.47 Billion | CN¥1.31 Billion | ▲ +4.3 pp |
| 2016 | 66.4% | CN¥2.80 Billion | CN¥4.22 Billion | CN¥1.42 Billion | ▼ -2.9 pp |
| 2015 | 69.3% | CN¥2.61 Billion | CN¥3.76 Billion | CN¥1.15 Billion | ▲ +8.3 pp |
| 2014 | 61.1% | CN¥2.28 Billion | CN¥3.73 Billion | CN¥1.45 Billion | ▲ +19.7 pp |
| 2013 | 41.4% | CN¥869.02 Million | CN¥2.10 Billion | CN¥1.23 Billion | ▲ +1.4 pp |
| 2012 | 40.0% | CN¥758.39 Million | CN¥1.89 Billion | CN¥1.14 Billion | ▲ +5.1 pp |
| 2011 | 34.9% | CN¥543.47 Million | CN¥1.56 Billion | CN¥1.01 Billion | — |